Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

By Van Driessche Ann   Van de Velde Ann   Nijs Griet   Braeckman Tessa   Stein Barbara   De Vries Jolanda   Berneman Zwi   Van Tendeloo Viggo  

Cytotherapy, Vol. 11, Iss. 5, 2009-09 ,pp. : 653-658

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

By Trepiakas Redas   Berntsen Annika   Hadrup Sine Reker   Bjørn Jon   Geertsen Poul F.   Straten Per Thor   Andersen Mads H.   Pedersen Anders E.   Soleimani Amir   Lorentzen Torben   Johansen Julia S.   Svane Inge Marie  

Cytotherapy, Vol. 12, Iss. 6, 2010-10 ,pp. : 721-734

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy

By Wong E C C   Maher V E   Hines K   Lee J   Carter C S   Goletz T   Kopp W   Mackall C L   Berzofsky J   Read E J  

Cytotherapy, Vol. 3, Iss. 1, 2001-01 ,pp. : 19-29

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma

By Guardino Ae   Rajapaksa R   Ong Kh   Sheehan K   Levy R  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 277-289

Ashgate Publishing Ltd

Access to resources Recommend Favorite

In vitro generation of dendritic cells derived from cryopreserved CD34⁺ cells mobilized into peripheral blood in lymphoma patients

By Enomoto M.   Nagayama H.   Sato K.   Xu Y.   Asano S.   Takahashi T.  

Cytotherapy, Vol. 2, Iss. 2, 2000-02 ,pp. : 95-104

Ashgate Publishing Ltd

Access to resources Recommend Favorite